# Sunitinib Drug Levels and Outcomes in Kidney Cancer

> **NCT01711268** · — · UNKNOWN · sponsor: **Western Sydney Local Health District** · enrollment: 35 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01711268
- **Lead sponsor:** Western Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2014-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711268, "Sunitinib Drug Levels and Outcomes in Kidney Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01711268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*